Scribe Therapeutics Expands Collaboration With Biogen to Second Target
Go back to Scribe Therapeutics Expands Collaboration With Biogen to Second Target| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 206.45 -2 (0.96%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $208.45 | 52 Week High | $333.65 | |||
| Open | $210.60 | 52 Week Low | $223.02 | |||
| Day High | $212.18 | P/E | 26.43 | |||
| Day Low | $206.11 | EPS | $7.81 | |||
| Volume | 454,085 | |||||

